Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
The IND application of Biosyngen BRG01 Therapy was accepted by CDE 2022-09-28 18:05
Biosyngen Gives Cell Therapy GMP Capabilities in Singapore A Boost 2022-09-28 17:34
Vernalis Research, a fully owned subsidiary of HitGen Inc., and Contera Pharma A/S announce a strategic collaboration in the field of RNA-targeting small molecules in neurology 2022-09-28 16:00
Pharming Announces US FDA Acceptance for Priority Review of its New Drug Application for Leniolisib 2022-09-28 13:00
Chugai Pharma Taiwan Awarded at the Asia Responsible Enterprise Awards 2022 for 'Cycling for Charity' under Social Empowerment Category 2022-09-28 12:30
ETANA HAS SECURED B ROUND FINANCING 2022-09-28 09:00
Ascletis Announces Dosing of the First Patient in the Phase IIb Expansion Cohort of ASC22 (Envafolimab) for Chronic Hepatitis B Functional Cure 2022-09-28 08:10
Chinese NMPA Approves Study of Telix Kidney Cancer Imaging Candidate 2022-09-28 06:50
First Patient in Australia Dosed with Illuccix® - Telix's Approved Prostate Cancer Imaging Agent 2022-09-28 05:00
TargEDys and Inoliva announce they have entered a distribution partnership to bring Satylia® to Turkey 2022-09-27 17:15
Sciwind Biosciences and SynerK Enter into Research Partnership to Discover and Develop Novel siRNA Therapeutics 2022-09-27 08:00
First Patient Enrolled in ProstACT TARGET Study 2022-09-27 05:00
In commemoration of World Pharmacists Day 2022, P&G Health lauds pharmacists and the role they play in providing whole-of-body healthcare to patients 2022-09-26 20:08
Brii Biosciences Announces Top-line Results from Phase 1 Study of BRII-296, A Long-Acting Therapy in Development for Postpartum Depression 2022-09-26 20:00
Nippon Express (China) Participates in 11th Global Pharmaceutical Cold Chain Summit 2022-09-26 15:00
Everest Medicines Receives Approval of Investigational New Drug Application from China NMPA for EVER001, a Novel BTK Inhibitor in Development for Treatment of Renal Diseases 2022-09-26 08:00
MGC Pharmaceuticals Successfully Developed Herbal-inspired Products for Treatment of Long COVID and COVID-19 2022-09-21 17:13
Sirnaomics to Present Latest Developments on siRNA Therapeutics for Cancer and GalAhead(TM) Platform Programs at the 2nd Annual Oligonucleotide Therapeutics and Delivery Conference 2022-09-20 22:40
Menarini and SciClone Sign Exclusive Licensing Agreement to Develop and Commercialize Vaborem® in China to Treat Antimicrobial Resistant Infections 2022-09-20 17:00
WuXi Biologics' Drug Substance and Drug Product Facilities Again Approved by U.S. FDA and EMA 2022-09-20 10:48
1 60 61 62 63 64 228